Skip to main content
Lotus Endometriosis Institute solid color logo
A beautiful landscape of lotus flowers

Can Scans and Tests Find Endometriosis? Know the Limits

What ultrasound, MRI, and newer “tests” can (and can’t) tell you

Flat vector illustration of interconnected transparent domes and tunnels with a glowing question mark, abstractly representing the limits of scans and tests for endometriosis.

If you’ve been told your ultrasound was “normal,” but your pain, bowel symptoms, bleeding, or infertility keep going, it can feel like the system is asking you to doubt your own body. This is one of the most common—and most frustrating—parts of the endometriosis diagnostic journey.


The hard truth is that endometriosis can be real even when scans look fine. Imaging can be extremely helpful, but it’s not a simple yes/no detector. And while research is moving toward less invasive testing (blood, menstrual fluid, advanced imaging), most of those options are still not ready for routine care.


This article pulls together findings from multiple recent studies and expert guidance to answer the patient question underneath so many appointments: “If I have endometriosis, why can’t you see it on a scan?”


First, a key distinction: “Diagnosing endometriosis” vs “mapping endometriosis”


When clinicians order a scan, they’re often trying to do one (or both) of these things:

  1. Estimate whether endometriosis (or adenomyosis) is likely based on patterns that imaging can detect
  2. Map where disease might be—especially deep disease involving bowel, bladder, ligaments, or the rectovaginal area—so surgery can be planned more safely


That difference matters because a scan can be “negative” for what it’s good at detecting, while still missing other lesion types or locations. Recent research comparing ultrasound and MRI in deep pelvic endometriosis shows agreement between the two tests is not uniformly “good” or “bad”—it changes by anatomic site, which helps explain why two scans (or two radiology reports) can disagree.


What ultrasound can do well (and where it can fall short)


Ultrasound is often the first-line test—and it can be genuinely useful


Transvaginal ultrasound (TVUS) is widely used because it’s accessible, relatively low cost, and can identify certain common endometriosis-related findings, especially ovarian endometriomas (“chocolate cysts”). In one recent cohort looking at deep pelvic endometriosis, ultrasound and MRI had near-perfect agreement for endometriomas/hemorrhagic cysts—meaning when those cysts were present, both tests typically saw them.


Ultrasound can also be strong for some bowel-related questions when performed by an experienced operator. In that same comparison study, ultrasound reported more rectosigmoid involvement than MRI, and the authors suggested MRI can be limited by bowel gas, which can interfere with how lesions appear.


But ultrasound has blind spots—especially for certain deep locations or uterine features


Even with good technique, ultrasound may miss disease in certain areas. For example, that same head-to-head research found MRI identified involvement in places ultrasound did not detect, including the rectovaginal septum and round ligaments.


And if adenomyosis is part of the picture, the limitations can become even more relevant. Another study comparing transvaginal ultrasound and pelvic MRI (using surgery/pathology as the benchmark in a surgical population) reported MRI performed better for uterine size/shape–related markers (features they linked to adenomyosis, such as uterine enlargement/asymmetry or abnormal junctional zone shape). The practical takeaway isn’t “ultrasound is bad”—it’s that some questions are simply harder for ultrasound to answer reliably, and that may be why an MRI is recommended after a “normal” scan.


What MRI adds—and why it’s often the next step



A 2025 European expert consensus on MRI for endometriosis offers a straightforward, patient-relevant pathway: MRI is recommended when TVUS is inconclusive, or when TVUS is negative but symptoms persist. The same consensus also supports MRI before surgery or procedures to improve disease mapping, and after surgery if symptoms continue.


So if you’re thinking, “Why are we doing an MRI if the ultrasound was normal?”—you’re not overreacting. There is expert agreement that MRI can be the right next step in exactly that situation.


MRI isn’t “perfect,” but it can see different things than ultrasound


MRI can be particularly helpful for areas that are difficult to evaluate on ultrasound and for clarifying uterine findings relevant to adenomyosis. But importantly, MRI and ultrasound can be complementary rather than interchangeable. In recent site-by-site comparisons, some locations had only moderate agreement between the two methods—meaning it’s completely possible for one test to flag something the other does not.


That’s also why technique details matter more than most patients are told. For example, the way MRI is performed (use of contrast or not, medications to reduce bowel motion, bladder filling, whether vaginal/rectal gel is used) can affect what’s visible—especially around the rectovaginal region or vagina. If you’ve had an MRI and felt like the report didn’t match your symptoms, it may not mean “nothing is wrong”; it may mean the study wasn’t optimized for the specific question, or that the disease type/location is simply hard to detect.


Structured reporting can improve care—even if patients don’t always see it


The same MRI consensus emphasized using standardized reporting and classifications to help surgeons and radiologists communicate clearly. In real life, not every center uses structured reports consistently, but the direction of the field is clear: better mapping and clearer language lead to better planning.


If you’re heading toward surgery, it’s reasonable to ask if your imaging report is designed to support surgical decision-making (not just “no mass seen”).


Why imaging can still miss endometriosis (even when it’s severe)


Patients often assume a “good test” should reliably rule out disease. Endometriosis breaks that rule for several reasons:

  • Not all endometriosis looks the same. Some lesions are superficial and small; others are deep and fibrotic; some form endometriomas. These behave differently on imaging.
  • Location changes visibility. Studies comparing MRI and ultrasound show detection depends heavily on where disease is (bowel, bladder, ligaments, rectovaginal space), with some sites consistently trickier than others.
  • Imaging shows patterns, not certainty. Even the more favorable studies acknowledge false positives and false negatives. Some imaging signs can overlap with other conditions (like fibroids or even normal uterine contractions affecting the junctional zone).
  • Operator skill and protocol matter. Especially for ultrasound, experience is a major variable; for MRI, preparation and protocol can change what is seen.


This is a big reason many people cycle through “normal test” → “maybe IBS/anxiety” → “keep trying birth control” before they ever get a comprehensive evaluation.


What about PET scans or advanced “molecular imaging”?


It’s understandable to wonder: “If PET scans find cancer, why can’t they find endometriosis?”


A recent review of radiopharmaceutical (“molecular”) imaging explains why common PET imaging (like FDG PET/CT) is not reliable for endometriosis. Pelvic organs normally take up FDG, and endometriosis uptake is inconsistent—published results range widely, from very low lesion correlation to variable patient-level detection. Translation: FDG PET is not a dependable endometriosis test, and incidental uptake shouldn’t be treated as proof.


The more exciting future direction is targeted imaging—especially approaches aimed at fibrosis and inflammation, such as Fibroblast Activation Protein (FAP)–targeted tracers (FAPI). Tissue research suggests FAP is often expressed in endometriosis lesions and correlates with fibrosis-related features; animal studies show promising lesion-to-background uptake. But human evidence is still early (including case-level reports), and the review highlights a major practical challenge: normal uterine/ovarian uptake can obscure disease in premenopausal patients. For now, this is best viewed as promising but investigational.


Still in pain? Get expert help now

Our specialists are here to help you understand your condition and explore your treatment options.

Schedule Your Visit

“Is there a blood test yet?” What current research really means


You may have seen headlines about a “new blood test for endometriosis.” The honest answer: not a clinically established one—but several lines of research are getting closer.


Blood-based miRNA panels: helpful for risk, not a standalone diagnosis (yet)


A 2026 study developing serum microRNA (miRNA) diagnostic models found moderate accuracy overall and better performance for deep infiltrating endometriosis (DIE) than for ovarian endometrioma. Notably, the DIE-focused model had high specificity (around 90%) but low sensitivity (about 51%)—meaning if it says “positive,” it may be meaningful, but a negative result would still miss many cases.


That pattern is common in early biomarker work: tests may eventually help triage (who should get expert imaging or referral sooner), rather than “replace laparoscopy.”


Immune-marker “liquid biopsy” panels: promising sensitivity, but false positives are a concern


Another 2026 study reported a circulating immune signature (a panel including inflammatory markers and soluble immune checkpoints) that distinguished surgical endometriosis cases from controls with high sensitivity (over 90%) and moderate specificity. That’s encouraging as a screening-style approach, but moderate specificity means a meaningful number of people without endometriosis could test positive.


Also important: participants were already going to surgery, and the sample didn’t include peritoneal-only disease—so we still don’t know how well it performs in the broader real-world population of people with pelvic pain.


Menstrual effluent testing: why it’s exciting, and why it’s not ready


One of the most patient-friendly research directions is testing menstrual effluent—fluid collected during a period (often with a menstrual cup). A 2026 systematic review found menstrual effluent reflects many biological features tied to endometriosis (progesterone resistance/decidualization problems, immune changes, pro-invasive signals, extracellular vesicle differences).


Some studies in that review reported remarkably high diagnostic accuracy for certain markers (for example, aromatase mRNA, TGF‑β1 protein, and functional decidualization assays). But there’s a catch that matters for patients: these were case–control studies with high risk of selection bias, and the review found no prospective validation cohorts. In plain language: Findings that seem strong in selected research populations often prove less effective in real-world clinics.


Still, this direction is worth watching because it could eventually mean home-based collection and a more direct window into uterine/endometrial biology than blood alone.


So why is laparoscopy still called the “gold standard”?


Because even the best available noninvasive methods can miss disease—and because laparoscopy can directly visualize lesions and allow biopsy for histology (tissue confirmation). Imaging can strongly suggest endometriosis, and it can help plan surgery, but it often can’t provide definitive proof for every lesion type or location.


That said, “gold standard” doesn’t mean “required for everyone right away.” It means that when the clinical stakes are high (severe symptoms, organ involvement, infertility decisions, treatment-resistant pain), and when imaging/clinical evaluation still leaves uncertainty, laparoscopy remains the most definitive tool we currently have.


Practical takeaways (how to use scans and tests without being gaslit)


  • A normal scan does not equal “no endometriosis.” It may mean “no endometrioma” or “no clearly visible deep lesions on this protocol, in this set of locations.”
  • Ask what the scan was meant to answer. Was it looking for endometriomas? Deep bowel disease? Adenomyosis? Surgical mapping?
  • If symptoms persist after a negative or unclear ultrasound, MRI is a guideline-supported next step. Especially when deep disease or adenomyosis is suspected, or when planning surgery.
  • Be cautious with headlines about new tests. Blood and menstrual-fluid tests are promising, but most are not yet validated for real-world diagnosis.


Questions to ask your doctor or radiology team


If you only ask a few things, make them these:

  • “Based on my symptoms, what locations are you most concerned about (bowel, bladder, uterosacral ligaments, rectovaginal area, ovaries, uterus)?”
  • “Was my ultrasound/MRI done in a way that’s optimized for deep endometriosis mapping?”
  • “If imaging is negative, what’s our plan for next steps—MRI, referral to an endometriosis specialist, medical therapy trial, or discussing laparoscopy?”
  • “Do you think adenomyosis could be contributing, and is MRI needed to clarify uterine findings?”
  • “Can you walk me through the report in plain language—what was checked, what was seen, and what could still be missed?”


What we still don’t know (and why your results may differ from someone else’s)


Even with better imaging standards and promising biomarker research, major gaps remain:


Imaging studies show performance varies by site, protocol, and experience, and even head-to-head comparisons find only moderate agreement in several pelvic locations. Biomarker studies (blood miRNA panels, immune signatures, menstrual effluent markers) often look strongest in selected surgical cohorts, and many lack the prospective, real-world validation needed before they can guide care reliably.


Most importantly: endometriosis is not one uniform disease, and different subtypes (deep infiltrating vs ovarian endometrioma vs superficial peritoneal disease) may require different diagnostic tools. That’s why your journey can be long—and why “normal tests” should never be used to dismiss persistent symptoms.


In the next post in this series, we’ll talk about what happens when tests don’t give clear answers: how doctors think through other possible causes, and how you can advocate for yourself without getting stuck in an endless loop of “wait and see.”

References

  1. Alkan, Kılıçkap. Agreement between magnetic resonance imaging and ultrasonography in deep pelvic endometriosis. Revista da Associação Médica Brasileira. 2025. PMID: 40172392 PMCID: PMC11964306

  2. Dong, Li, Li. Efficacy of Transvaginal Ultrasound vs Pelvic MRI in Preoperative Diagnosis of Pelvic Endometriosis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2025. PMID: 40205719 PMCID: PMC11998614

  3. Thomassin-Naggara, Dolciami, Chamie et al.. ESUR consensus MRI for endometriosis: indications, reporting, and classifications. European Radiology. 2025. PMID: 40425757 PMCID: PMC12559033

  4. Napolitano, Speltri, Martini et al.. Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals. Molecules. 2025. PMID: 41515390 PMCID: PMC12786799

  5. Ravaggi, Bergamaschi, Conforti et al.. Serum miRNA-based diagnostic models for endometriosis: from discovery to validation. Human Reproduction (Oxford, England). 2026. PMID: 41270284 PMCID: PMC12864148

  6. . Endoscopic management of ureteral injuries arising from gynecologic procedures. BJUI Compass. 2026. PMID: 41696655 PMCID: PMC12894419

  7. Hernández, Fernández-Medina, Araiz et al.. Identification of a circulating immunological signature as a liquid biopsy approach for the diagnosis of endometriosis. Scientific Reports. 2026. PMID: 41577934 PMCID: PMC12902033

  8. Wei, Zhang, Weng et al.. Functional restoration of uterine architecture and fertility via a 3D-printed biomimetic scaffold: The role of macrophage-driven immunomodulation. Materials Today Bio. 2026. PMID: 41809374 PMCID: PMC12969655

  9. Watrowski, Kostov, Tsoneva et al.. Menstrual Effluent in the Pathogenesis and Diagnosis of Endometriosis—A Systematic Review. Diagnostics. 2026. PMCID: PMC12984173

Quick Answers

How rare is endosalpingiosis?

Endosalpingiosis is generally considered uncommon, but “how rare” it is depends heavily on who’s being studied and how it’s found. Many cases are discovered incidentally on pathology—meaning tissue is identified under the microscope after surgery done for other reasons—so it’s likely underrecognized in the general population. In other settings (like surgical cohorts), it may appear more often simply because more tissue is being sampled and examined carefully.


What matters most for patients is that endosalpingiosis can be confused with endometriosis on imaging or even at surgery, yet it doesn’t always behave the same way clinically. If you’ve been told you have endosalpingiosis and you also have pelvic pain, bowel/bladder symptoms, or fertility concerns, our team can help interpret what that finding means in the context of your symptoms and operative/pathology reports. You’re welcome to explore our educational content on related endometriosis and uterine conditions, and reach out to schedule a consultation if you want a personalized plan.

Read full answer

Can endometriosis cause a painful bump near the anus?

Yes. Endometriosis can contribute to pain and pressure around the rectum and anal area, especially when disease involves the rectum/rectosigmoid region or nearby tissues. Many patients describe deep pain with bowel movements, rectal pressure, or symptoms that flare around their cycle, and those patterns can fit bowel or deep infiltrating endometriosis.


That said, a sensitive bump on the anus itself is more often something else (like a hemorrhoid, fissure, skin infection/abscess, or another localized anal/skin condition). In some cases, pelvic disease can coexist with these issues, which is why we don’t assume every finding is endometriosis—or dismiss it as “nothing.”


If you’re noticing a new, persistent, or worsening bump—especially if it’s very tender, draining, bleeding, or associated with fever—we want to evaluate the full picture. Our team can sort out whether your symptoms point toward bowel endometriosis, a separate anorectal condition, or both, and plan next steps such as a focused exam and, when appropriate, expertly interpreted imaging to map possible deep disease.

Read full answer

What is the AAGL endometriosis classification system?

The AAGL endometriosis classification system is a standardized way surgeons describe what they found at surgery—where endometriosis is located, how extensive it is, and how complex the disease appears. Its goal is to create a more consistent “shared language” than older staging alone, especially for cases where symptoms and imaging don’t tell the full story.


Unlike simple stage labels, AAGL-style classification is meant to better capture real-world surgical complexity, including deeper disease that can involve structures like the uterosacral ligaments, rectovaginal space, bowel, bladder, or ureters. This matters because location and depth (for example, deep infiltrating disease) can drive very different symptoms and may change imaging choices and surgical planning. If you’re reading an operative report or trying to make sense of what a surgeon told you, our team can help translate the classification into what it likely means for your body, your symptoms, and the treatment path you’re considering.

Read full answer

When is menstrual bleeding considered too heavy?

Menstrual flow is generally “too heavy” when it consistently disrupts your life or overwhelms your usual period products—think flooding or soaking through pads/tampons quickly, passing frequent or large clots, needing to double up, or bleeding long enough that you can’t plan around it. Another major clue is fatigue, dizziness, or shortness of breath that can come with iron deficiency from ongoing blood loss. If you’re timing your day around bathrooms, waking at night to change products, or avoiding work, exercise, travel, or sex because of bleeding, that’s not something we consider “normal.”


Heavy bleeding is a symptom, not a diagnosis, and common underlying drivers include adenomyosis, fibroids, hormonal imbalance, and sometimes endometriosis—especially when heavy bleeding shows up with severe cramps or deep pelvic pain. Because imaging and symptoms don’t always match (a scan can look “mild” while symptoms are intense), we take a symptom-led approach and look at the full pattern, including pain, pressure, clots, cycle timing, and any signs of anemia. If your bleeding feels like it’s escalating or you’ve been told to “just live with it,” our team can help you sort out likely causes and build a plan that targets the source—not just the bleeding.

Read full answer

How does estrogen affect the endometrium?

Estrogen is one of the main hormones that drives endometrial growth. In the first half of the menstrual cycle, rising estrogen signals the endometrium to thicken and rebuild after a period, preparing the uterus for a possible pregnancy. It also influences the local immune and inflammatory environment in the uterus, which is part of why hormonal shifts can change bleeding patterns and pain.


When estrogen’s growth signals are strong—and progesterone’s “calming” effect is weaker than expected (often described as progesterone resistance)—the endometrium can behave in a more persistently inflamed, reactive way. This hormone–inflammation pattern is especially relevant in estrogen-dependent conditions like adenomyosis and endometriosis, where tissue similar to the endometrium can contribute to ongoing symptoms. If you’re trying to make sense of heavy bleeding, severe cramping, or cycle-linked pelvic pain, our team can help you connect the hormonal biology to what you’re feeling and review next steps for diagnosis and treatment.

Read full answer

Reach Out

Have a question?

Lotus Endometriosis Institute provides California-based surgical evaluation and advanced excision care for patients with suspected endometriosis, adenomyosis, complex pelvic pain, and related conditions.


Many patients contact us from outside California to learn whether traveling for in-person evaluation and possible surgery may be appropriate.

Call Us

(424) 255-1340

(805) 920-0909

Fax: (805) 935-4338

Santa Monica, CA

2121 Santa Monica Blvd, Santa Monica, CA 90404

Operating Hours

8:00 am - 5:00 pm
Monday - Friday

Arroyo Grande, CA

154 Traffic Way, Arroyo Grande, CA 93420